Volume 4 Issue 3 - International Pharmaceutical Industry

Current Edition

Clinical Research v4i3

Action Duchenne – Skip Duchenne Campaign

Nick Catlin at Charity Action Duchenne provides an overview of the research into a cure and effective medicines for Duchenne/Becker Muscular Dystrophy. The cha...

28 September 2012 Clinical Research v4i3 | Volume 4 Issue 3 campaign | duchenne

Continue Reading →

Packaging v4i3

Bag-on-Valve – Optimal Solution for Pharma Products

With tax-based healthcare service burdened by increasingly higher costs for pharmaceuticals and the ever-more stringent regulation governing the introduction of ...

28 September 2012 Packaging v4i3 | Volume 4 Issue 3 packaging | pharma

Continue Reading →

Clinical Research v4i3

Planning and Performing Clinical Trials in Children and Adolescents

Jaypreet Dhillon, Editorial Manager of Pharma Publications, Interviews Dr. Hermann Schulz, Chief Executive Officer INTERLAB Central Lab Services – Worldwid...

28 September 2012 Clinical Research v4i3 | Volume 4 Issue 3 children | clinical trial

Continue Reading →

Packaging v4i3

Labelling and its Role in Pharmaceutical Packaging

The ever-increasing legislative demands for patient information on pharmaceutical labelling often poses a packaging challenge to manufacturers and brand-owners. ...

28 September 2012 Packaging v4i3 | Volume 4 Issue 3 labelling | packaging

Continue Reading →

Drug Discovery, Development & Delivery v4i3

Straightforward or Challenging? Why It Matters Where You Place DM&PK Studies

Medical research has been a major underlying factor leading to the dramatic reduction in overall morbidity and mortality in the 20th century. In his book, The De...

28 September 2012 Drug Discovery, Development & Delivery v4i3 | Volume 4 Issue 3 DM&PK | drug discovery

Continue Reading →

Clinical Research v4i3

Clinically-relevant in vitro and in vivo Oncology Models for Drug Discovery

The success rate in predicting clinical efficacy of anti-cancer modalities using current xenograft models has been reported to be only 30-40%. Standard xenograft...

28 September 2012 Clinical Research v4i3 | Volume 4 Issue 3 clinical | drug discovery

Continue Reading →

Regulatory & Marketplace v4i3

Health – Made in Germany

Health – Made in Germany The market for healthcare is gaining steadily in global importance and offers great promise f...

28 September 2012 Regulatory & Marketplace v4i3 | Volume 4 Issue 3 germany | health

Continue Reading →

Manufacturing v4i3

A Fluid Process

The control of fluid flow – both gas and liquid – forms an essential part of many different types of medical equipment, from boiler control on steam sterilisers ...

28 September 2012 Manufacturing v4i3 | Volume 4 Issue 3 fluid | manufacturing

Continue Reading →

Clinical Research v4i3

Centralised ECGs Help Ensure Cardiac Safety of Obesity Drugs

Obesity rates have dramatically increased over the past 20 years, making it one of the most prevalent health problems in the world. Despite this, there are only ...

28 September 2012 Clinical Research v4i3 | Volume 4 Issue 3 cardiac | drug

Continue Reading →

Clinical Research v4i3

Allergy and Biopharmaceutical Therapy, Part 1: Background and Current Treatment Regimens

A fairly good knowledge base concerning various steps in allergic reactions now exists, but despite this knowledge the prevalence of allergic diseases is still i...

28 September 2012 Clinical Research v4i3 | Volume 4 Issue 3 allergy | biopharmaceutical

Continue Reading →